Filana names Biopharma executive to board
Filana Therapeutics appointed Jill M. Quigley to its board to support simufilam development, a positive move for the company's growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed